Health
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store – Yahoo News Australia
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from…
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to dosing, including one where two full-strength doses were applied, which was 62% effective, and a much more promising dosage trial which used one half-dose and one full-strength dose to follow — that one was 90% effective.
Oxford’s results may not have…
-
Noosa News18 hours agoIncrease in extreme weather events poses ‘substantial risk’ to blood supplies, researchers warn
-
General22 hours agoGerman palliative care doctor with alleged ‘lust for murder’ accused of killing 15 patients
-
Noosa News8 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
Noosa News13 hours agoManjimup engineer turns previously wasted avocados into liquid gold